Studies by Scarpa et al. showed that UC patients with dysplasia displayed higher levels of CD80 than those without dysplasia, and that CD80 levels were significantly higher in UC patients with dysplasia compared to those with non UC-related dysplasia (57), suggesting that CD80 may be involved in immune surveillance in UC patients (43, 44). The gene discussed is CD80; the disease is dysplasia.